Crosslinked Polysaccharide Beads and Their Biomedical Uses

Patent metadata

Field	Value
Publication number	US-2019083400-A1
Application number	US-201816197409-A
Country	US
Kind code	A1
Filing date	Nov 21, 2018
Priority date	Aug 31, 2010
Publication date	Mar 21, 2019
Grant date	—

Abstract

The present inventions relates to beads as biocompatible material adapted for use within the human or animal body. Said beads arc highly useful for tissue engineering, in situ tissue regeneration, as well as for drug and/or cells delivery. In addition, said beads may support biotechnological applications such as cell carriers.

First claim

1 - 9 . (canceled)

10 . A crosslinked polysaccharide bead having a substantially spherical or ovoid shape obtained by
a) preparing an alkaline aqueous solution comprising at least one polysaccharide and a cross linking agent; b) in the absence of surfactant dispersing said alkaline aqueous solution into an hydrophobic phase consisting of a vegetal oil, in order to obtain a water-in-oil (w/o) emulsion; and c) transforming the w/o emulsion into beads by placing said w/o emulsion at a temperature from about 4° C. to about 80° C. for a sufficient time to allow the cross-linking of said at least one polysaccharide; wherein said polysaccharide is selected from the group consisting of mixtures of dextran and pullulan and mixtures of dextran, pullulan and fucoidan, wherein said crosslinked polysaccharide bead is free of any organic solvent and surfactant, and wherein said crosslinked polysaccharide bead has a mean diameter of more than 10 μm.

11 - 18 . (canceled)

19 . The bead according to claim 10 , wherein the vegetal oil is selected from canola oil, corn oil, cottonseed oil, safflower oil, soybean oil, extra virgin olive oil, sunflower oil, palm oil, MCT oil, and trioleic oil.

20 . The bead according to claim 19 , wherein the vegetal oil is canola oil.

21 . The bead according to claim 10 , wherein the polysaccharide is a mixture of pullulan/dextran.

22 . The bead according to claim 21 , wherein the mixture of pullulan/dextran is in a ratio of 75:25 w/w.

23 . The bead according to claim 10 , wherein the cross-linking agent is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl3), epichlorohydrin, formaldehydes, carbodiimides, and glutaraldehydes.

24 . The bead according to claim 10 , wherein the alkaline aqueous solution further comprises a porogen agent.

25 . The bead according to claim 24 , wherein the porogen agent is selected from the group consisting of sodium chloride, calcium chloride, ammonium carbonate, ammonium bicarbonate, calcium carbonate, sodium carbonate, sodium bicarbonate and mixtures thereof.

26 . The bead according to claim 10 , wherein the alkaline aqueous solution further comprises hydroxyapatite.

27 . The bead according to claim 10 , wherein the alkaline aqueous solution further comprises a drug.

Assignees

• Inst Nat Sante Rech Med
• Univ Paris Diderot Paris 7

Inventors

• Letourneur Didier
• Le Visage Catherine
• Derkaoui Sidi Mohammed

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• A61K9/0024

  Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L) · CPC title

• A61L27/20

  Polysaccharides · CPC title

• A61L2430/20

  for reconstruction of the heart, e.g. heart valves · CPC title

• C08B37/0021

  Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran · CPC title